Introduction
Bile stone disease is a rare condition in childhood. It is equally frequent in boys and girls in early childhood but its prevalence in girls exceeds that of boys after adolescence. Since some patients have an asymptomatic course, it is difficult to determine the exact prevalence of the condition. To date, a limited number of studies have reported a prevalence of 0.13% to 0.5% [1] . In children, hemolytic disorders, ceftriaxone use, and total parenteral nutrition (TPN) are the major causes implicated in bile stone formation [2] . Herein we report the case of a 2.5-year-old child with idiopathic chronic cholecystsitis treated with laparoscopic cholecystectomy, who received a delayed diagnosis after a 2-year history of abdominal pain.
Case Report A 2.5-year-old boy was admitted to Pediatric Surgery clinic with intermittent abdominal pain and nausea that had been occurring for 2 years. In an interview with his family it was learned that his abdominal pain had intensified during the week before his presentation, and that an abdominal ultrasonography performed at an outside center 3 months earlier had revealed a few millimetric bile stones, for which the patient had been put on ursodeoxycholic acid (UDCA) at a dose of 30 mg/kg/day. He had not had clinical findings such as shortness of breath, wheezing, excessive sputum, excessive sweating, or foul-smelling stool. He had no known disease, previous surgery, or long-term antibiotic use. The patient had been born at term via normal spontaneous vaginal route. On physical examination he had tenderness on palpation and guarding at the upper right abdominal quadrant and epigastric region; he had no hepatomegaly, splenomegaly, or fever. During laboratory investigation the following results were determined: WBC: 9.400/mm3, Hb: 11.3 g/dL, PLT: 320/ uL, MCV: 78.6 fL, MCHC: 32.8 g/dL, AST: 45 U/L, ALT: 49 U/L, T Bil:0.6 mg/dL, D Bil: 0.2 mg/dL, LDH: 140 U/L, INR: 0.81, and CRP: 15 mg/L. Other biochemical tests were also within the normal range. No pathology was found on the peripheral blood smear. Direct Coombs test was negative. An abdominal ultrasonography (USG) revealed a few lymphadenopathies of 9x6 mm at the hepatic hilus, as well as 2 bile stones measuring 4 mm and 5 mm in the gall bladder. The wall thickness of the gall bladder was 3 mm; there was no intrahepatic or extrahepatic bile duct dilatation. From these results, hematologic disease and cystic fibrosis were excluded as risk factors. Because of this, the case was identified as idiopathic chronic cholecystitis. Based on the findings indicating cholecystitis, the patient was scheduled for laparoscopic cholecystectomy. Under general anesthesia, a 10-mm trocar was entered into the abdominal cavity from the umblicus, a 5-mm trocar from the epigastric region, and two 3-mm trocars on the midclavicular and anterior axillary lines from the right subcostal region. The abdominal cavity was inflated with CO2 gas to a pressure level of 10 mmHg. A standard laparoscopic cholecystectomy procedure was performed and the operation was completed without placing a drain pipe. The patient was discharged with full recovery 2 days later. Histopathological examination showed chronic cholecystitis (Figure 1a,b) . He returned for a follow-up appointment 7 days later, at which time he had no clinical problem at all.
Discussion
The literature data about bile stone disease, which had been considered an adulthood disease until recently, have mostly come from adult patients. Since its introduction as a readily accessible and non-invasive diagnostic tool, USG is now more commonly used in children, leading to an increased prevalence of identified cases of bile stone disease in this age group. As therapeutic options and care continue to improve, the number of children who survive chronic conditions, premature birth, or low birthweight and who receive prolonged TPN treatment has increased, causing a parallel increase in the prevalence of bile stone disease. While cholesterol stones are the most common bile stone variety in adults, 70% of pigment stones in children develop from hemolytic disorders [3] . Risk factors for bile stone disease in children have been defined as hemolytic diseases, obesity, premature birth, sepsis, TPN, chronic liver disease, short bowel syndrome, previous abdominal surgery, cystic fibrosis, IgA deficiency, Gilbert disease, ceftriaxone or diuretic use, and inflammatory bowel disease. However, some prior studies have failed to define any risk factor in 23% to 52% of the affected patients, which are said to be idiopathic [2] . Our patient similarly had no risk factor for this disorder. Unlike adults, children usually develop cholelithiasis secondary to hemolytic or non-hemolytic disorders. Sickle cell anemia, hereditary spherocytosis, and thalassemia are the major causes of hemolytic cholelithiasis. It has been reported that sickle cell anemia is associated with bile stone disease at a rate of 50% in 20 years. In these patients, USG typically detects bile mud, which is known to increase the risk of bile stones later in the disease course; therefore, such patients are offered elective cholecystectomy even if they are asymptomatic. As patients age, the differentiation between hemolytic crisis of sickle cell anemia and biliary colic may become difficult; therefore, an early intervention would reduce the morbidity and mortality of the disease [4] . Ceftriaxone, a third generation cephalosporin, may reach an intracystic concentration that is 20-150 times greater than its serum concentration. The chance of developing bile stones particularly increases with prolonged, high-dose ceftriaxone administration. Ceftriaxone-induced bile stones spontaneously disappear when the treatment is discontinued. Therefore, this condition is also called "pseudolithiasis." Studies have confirmed that bile stones develop at a rate of 25-30% and spontaneously disappear shortly after treatment discontinuation in patients who are administered ceftriaxone [5] . UDCA and chenodeoxycholic acid that are used to treat bile stone disease act by lowering the amount of cholesterol released into bile and thereby reducing biliary cholesterol concentration. However, they have been found to be ineffective in dissolving bile stones in a majority of cases, and even when they work, bile stones recur in 50% of cases. However, UDCA and chenodeoxycholic acid are associated with eliminating symptoms and preventing further occurrence of symptoms during follow-up. In a study of 117 pediatric subjects with nonceftriaxone associated bile stones, UDCA managed to eliminate stones in only 4.2% of subjects, 2 of whom later had recurrent stones. Another study reported improved symptoms in 45 (65%) of 69 cases [6] . In our patient, however, stones did not disappear and abdominal pain was not relieved despite a 3-month course of UDCA treatment. It may be prudent to continue clinical and ultrasonographic follow-up in patients who have no specific symptoms or in those whose stones have disappeared. Cholecystectomy is the single effective therapeutic option in patients with recurrent biliary symptoms or complications; laparoscopic cholecystectomy is currently the technique of choice thanks to a shorter hospital stay and a lower cost associated with its use [7] . After the first published studies on laparoscopic cholecystectomy in adults, successful laparoscopic cholecystectomy operations with favourable outcomes were first reported in children in 1991 [8] . Laparoscopic cholecystectomy has recently become the standard technique of surgical treatment for gall bladder disease in children.
Conclusion
Cholelithiasis is rare in children, and the fund of knowledge about this condition is insufficient. In children with bile stones, clinicians should be vigilant against some underlying disorders, and any history of medication use should be thoroughly questioned. Periodic ultrasonographic studies should be performed in cases with hemolytic diseases. Laparoscopic cholecystectomy should be performed when treatment is indicated.
